[Matt_Cutts]

(Disclosure: I invested in this company at YC back in 2018, when it was Osh’s Affordable Pharmaceuticals)

That article is a bit short on details. Some other recent articles I thought were more helpful included https://www.healio.com/news/rheumatology/20220428/mark-cuban... and https://www.drugtopics.com/view/the-good-the-bad-and-the-mis... . The second article is written more from the perspective of independent pharmacies.

The first article includes this snippet: "If there is reason for optimism, though, it lies with the medical background of Oshmyansky, the company’s co-founder and CEO, according to Gewanter.

'The radiologist Cuban is working with knows the business,' Gewanter said. 'Between the two of them, it is not difficult to imagine that they will figure out where the gaps are and how to exploit them. We can only hope that when they do, our patients will be the beneficiaries.' "

I think YC made a fantastic choice including Alex's company in YC, and it's been a pleasure seeing what Alex has done and is doing. I'll stop there for now.